Gilternib 40mg (Gilteritinib)

Gilternib 40 mg (Gilteritinib) - Targeted Therapy for AML

Gilternib 40 mg (Gilteritinib) is an advanced oral chemotherapy medication used in the targeted treatment of a specific type of blood cancer. This potent kinase inhibitor is crucial for managing acute myeloid leukemia (AML) that has not responded to previous treatments.

This medication is manufactured by Everest Pharmaceuticals Ltd., a leading pharmaceutical company, and is supplied globally by Mediaid Pharmacy. We are a trusted partner in providing genuine oncology medications to patients, hospitals, and healthcare providers worldwide. This product is available for Export Only.

What is Gilternib 40 mg (Gilteritinib)?

Gilternib contains the active ingredient Gilteritinib, which belongs to a class of drugs known as FLT3 inhibitors. In many AML cases, a mutation in the FLT3 gene causes cancer cells to grow and divide uncontrollably. Gilternib works by specifically targeting and blocking the activity of this mutated FLT3 protein, thereby slowing or stopping the proliferation of leukemia cells.

Indications for Use

Gilternib 40 mg is indicated for the treatment of adult patients who have relapsed or refractory (R/R) acute myeloid leukemia (AML) with a specific FMS-like tyrosine kinase 3 (FLT3) mutation. A doctor must confirm the presence of this mutation through a validated test before initiating treatment.

Dosage & Administration

The standard recommended starting dose of Gilternib is 120 mg (which is three 40 mg tablets) taken orally once daily. The 40 mg tablet strength is essential for achieving this correct starting dose and for any subsequent dose adjustments your oncologist may recommend based on your response and tolerance.

• Take this medication at the same time each day, with or without food.
• The tablets should be swallowed whole with water. Do not break, crush, or chew the tablets.
• Always follow the dosage instructions provided by your qualified healthcare provider.

Manufacturer – Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a prominent and innovative pharmaceutical company. It is known for its state-of-the-art manufacturing facilities and commitment to producing high-quality, complex medications, particularly in the field of oncology. Adhering to strict international Good Manufacturing Practices (GMP), Everest ensures that every product, including Gilternib, meets global standards of safety and efficacy.

Supplier – Mediaid Pharmacy

Mediaid Pharmacy is your trusted global supplier and distributor of specialized oncology medicines, including Gilternib 40 mg. We are committed to bridging the gap in healthcare by ensuring access to authentic, life-saving treatments for patients everywhere.

Mediaid Pharmacy is known for:

• Worldwide Shipping: We reliably ship "Export Only" medications to patients, pharmacies, and hospitals around the globe.
• Guaranteed Authenticity: We source all products directly from Everest Pharmaceuticals and other certified manufacturers.
• Patient-Centric Service: Our knowledgeable team is available to assist with your inquiries and ensure a secure and confidential ordering process.
• Competitive Pricing: We strive to offer affordable access to essential cancer treatments.

Why Choose Gilternib 40 mg from Mediaid Pharmacy?

• • Targeted Therapy: Specifically acts on the FLT3 mutation, a key driver of AML.
  • Proven Efficacy: A vital treatment option for patients with relapsed or refractory AML.
  • Flexible Dosing: The 40 mg strength allows for precise dosing and adjustments.

• High-Quality Manufacturing: Produced under strict GMP guidelines by Everest Pharmaceuticals.
• Global Availability: Distributed efficiently and reliably by Mediaid Pharmacy worldwide.

Frequently Asked Questions (FAQs)

Q: What is the 40 mg tablet used for?
A: The 40 mg tablet is the base strength. The standard starting dose is 120 mg, which requires taking three 40 mg tablets at one time. This strength also allows for dose reductions if needed.

Q: Can Gilternib be taken with food?
A: Yes, Gilternib (Gilteritinib) can be taken with or without food. It should be taken at the same time each day.

Q: Is this product authentic?
A: Yes, Mediaid Pharmacy guarantees 100% authenticity. We source Gilternib 40 mg directly from Everest Pharmaceuticals.

Conclusion

Gilternib 40 mg (Gilteritinib) is a critical, targeted therapy for patients with FLT3-mutated AML that has relapsed or is refractory to other treatments. Manufactured by Everest Pharmaceuticals and supplied by Mediaid Pharmacy, this product represents a high-quality, reliable, and accessible option for oncologists and patients worldwide.

Contact Us to Order or Inquire

For the latest pricing, bulk orders, or to speak with our pharmacy team about Gilternib 40 mg (Gilteritinib), please contact us. We are available 24/7 to support your healthcare needs.

WhatsApp/WeChat: +8801773428128